Birzeit Pharmaceuticals Stock: price and insider trades · Palestine
1 insider bought shares over the last 90 days, the latest by فهيم حسن حسين زبيدي, filed 24 Aug 2026.
Birzeit Pharmaceuticals: what insiders have been doing
Every trade that managers of Birzeit Pharmaceuticals disclose to PCMA / Palestine Exchange is tracked on this page. Over the twelve months to 15 November 2026, 19 filings were filed, from 9 insiders.
On the market, 5 insiders bought (12 purchases) while 6 insiders sold (7 sales). The totals exclude 19 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 3 board members and 1 senior executive among the declarants.
The clock since the last published purchase (24 August 2026) now reads 85 days.
Across the 51 companies tracked on its exchange, the median is 9 filings; at 19 filings, this issuer sits above that mark. Our records for Birzeit Pharmaceuticals go back to 2018, with 32 purchases and 15 sales on the open market in total.
This summary is built from PCMA / Palestine Exchange disclosures alone and does not predict where the share price will go.
Who traded when
BuySale+3 other insiders
Financial data
· cache
T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.
- 874 sharesSharePEXPEX:9960ef5e5bd3-1Canonical exit: 22 Nov 2026 (T+90)
- 1,056 sharesSharePEXPEX:04c28f62da08-1Canonical exit: 17 Nov 2026 (T+90)
- 5,634 sharesSharePEXPEX:f5f6bbe72536-1Canonical exit: 6 Sept 2026 (T+90)
- 20,000 sharesSharePEXPEX:b9a0f3b02bb1-1Canonical exit: 6 Sept 2026 (T+90)
- 9,366 sharesSharePEXPEX:c316c630d629-1Canonical exit: 31 Aug 2026 (T+90)
- 27,701 sharesSharePEXPEX:4b067b90a5cf-1
- 22,100 sharesSharePEXPEX:5ed8c895c506-1Canonical exit: 19 Apr 2026 (T+90)
- 100 sharesSharePEXPEX:bcff85db3091-1Canonical exit: 6 Apr 2026 (T+90)
- 15,000 sharesSharePEXPEX:fd29b654de9f-1Canonical exit: 31 Mar 2026 (T+90)
- 219,723 sharesSharePEXPEX:44eeef79fc5f-1Canonical exit: 31 Mar 2026 (T+90)
- 20,000 sharesSharePEXPEX:c0473d89f41e-1
- 6,665 sharesSharePEXPEX:7980031aa97a-1
- 27,705 sharesSharePEXPEX:9c3fdfb22283-1
- 1,000 sharesSharePEXPEX:68f6bd4811d3-1
- 60,582 sharesSharePEXPEX:c4a9566c6b9d-1Canonical exit: 30 Mar 2026 (T+90)
- 9,197 sharesSharePEXPEX:013584b3e6e6-1Canonical exit: 17 Mar 2026 (T+90)
- 73,850 sharesSharePEXPEX:93cb39a16a71-1
- 59,500 sharesSharePEXPEX:c65f41b718e5-1Canonical exit: 1 Mar 2026 (T+90)
- 600 sharesSharePEXPEX:02fc210ab2fa-1
- 52,400 sharesSharePEXPEX:b60c6ff29f73-1
- 600 sharesSharePEXPEX:051b39ed598a-1Canonical exit: 4 Feb 2026 (T+90)
- 100 sharesSharePEXPEX:977d63d7a870-1
- 1,200 sharesSharePEXPEX:46ff17a458a6-1Canonical exit: 7 Jan 2026 (T+90)
- 341 sharesSharePEXPEX:ac0fbc0dc4ff-1Canonical exit: 17 Dec 2024 (T+90)
- 3,500 sharesSharePEXPEX:b59d0fbf43e7-1
25 of 47 declarations
About Birzeit Pharmaceuticals
Birzeit Pharmaceuticals is a pharmaceutical company based in Palestine, specializing in the production of generic drugs and pharmaceutical products. It aims to improve access to healthcare in the region.
Written on 14 November 2026 from the filings and market data available that day. Live figures are in the blocks above.
The weekly insider digest, free
One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.